COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 592.3 | 1 | 0124-0667 | 75.29 | 666.23 | 255 | 61.01 | 0.861 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 365.1 | 1 | 0125-0677 | 59.44 | 677.46 | 367 | 73.74 | 0.848 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 524.9 | 1 | 0126-0683 | 690.93 | 683.68 | 237 | 57.11 | 0.913 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 333.9 | 1 | 0127-0686 | 20.18 | 685.76 | 352 | 73.26 | 0.824 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 440.8 | 1 | 0128-0684 | 273.91 | 684.26 | 249 | 60.87 | 0.845 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 380.4 | 1 | 0129-0693 | 915.46 | 693.02 | 290 | 65.36 | 0.853 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 358.0 | 1 | 0130-0701 | 579.21 | 702.80 | 368 | 72.43 | 0.882 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 457.3 | 2 | 0001-0044 | 402.32 | 43.52 | 252 | 60.87 | 0.855 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1057.8 | 2 | 0002-0047 | 546.79 | 46.75 | 377 | 74.43 | 0.855 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 343.9 | 2 | 0003-0045 | 673.20 | 45.53 | 381 | 73.60 | 0.884 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 492.3 | 2 | 0004-0049 | 443.67 | 49.45 | 286 | 65.01 | 0.850 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 396.1 | 2 | 0005-0054 | 106.51 | 53.86 | 348 | 73.26 | 0.815 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 392.8 | 2 | 0006-0052 | 743.31 | 52.03 | 279 | 62.43 | 0.900 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 327.4 | 2 | 0007-0054 | 139.17 | 54.86 | 280 | 64.43 | 0.848 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1174.8 | 2 | 0008-0067 | 28.86 | 65.71 | 380 | 74.67 | 0.856 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 472.7 | 2 | 0009-0077 | 470.04 | 76.71 | 312 | 68.18 | 0.843 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 445.9 | 2 | 0010-0072 | 721.48 | 72.01 | 287 | 65.94 | 0.829 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 405.3 | 2 | 0011-0074 | 183.67 | 73.87 | 277 | 62.28 | 0.897 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 573.0 | 2 | 0012-0080 | 815.81 | 78.97 | 283 | 65.50 | 0.829 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 392.8 | 2 | 0013-0082 | 518.19 | 82.42 | 330 | 77.50 | 0.690 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 421.7 | 2 | 0014-0083 | 889.92 | 82.14 | 281 | 62.77 | 0.896 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 336.6 | 2 | 0015-0093 | 931.34 | 92.92 | 316 | 69.26 | 0.828 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 480.6 | 2 | 0016-0102 | 144.94 | 102.35 | 374 | 75.50 | 0.825 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 505.6 | 2 | 0017-0105 | 565.73 | 104.91 | 454 | 81.26 | 0.864 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 523.6 | 2 | 0018-0111 | 22.99 | 111.27 | 235 | 56.53 | 0.924 |